These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 32432601)

  • 1. Pelargonidin ameliorates CCl
    Shi YS; Li XX; Li HT; Zhang Y
    Food Funct; 2020 Jun; 11(6):5156-5165. PubMed ID: 32432601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis.
    Zhu Z; Hu R; Li J; Xing X; Chen J; Zhou Q; Sun J
    Int Immunopharmacol; 2021 Jul; 96():107660. PubMed ID: 33862553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esculin inhibits hepatic stellate cell activation and CCl
    Xu S; Chen Y; Miao J; Li Y; Liu J; Zhang J; Liang J; Chen S; Hou S
    Phytomedicine; 2024 Jun; 128():155465. PubMed ID: 38471319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling.
    Ge C; Tan J; Lou D; Zhu L; Zhong Z; Dai X; Sun Y; Kuang Q; Zhao J; Wang L; Liu J; Wang B; Xu M
    Redox Biol; 2022 May; 51():102274. PubMed ID: 35240537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.
    Xuanfei L; Hao C; Zhujun Y; Yanming L; Jianping G
    Oncotarget; 2017 Mar; 8(13):21015-21030. PubMed ID: 28423499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schisandrin B attenuates CCl
    Chen Q; Zhang H; Cao Y; Li Y; Sun S; Zhang J; Zhang G
    Drug Des Devel Ther; 2017; 11():2179-2191. PubMed ID: 28794616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
    Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria-targeted reactive oxygen species blockor SS-31 blocks hepatic stellate cell activation and alleviates hepatic fibrosis by regulating NLRP3 inflammasomes.
    Liu L; Wei Y; Xie N; Cai H; Lin Y
    Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):183-188. PubMed ID: 38430023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation.
    Cai SM; Yang RQ; Li Y; Ning ZW; Zhang LL; Zhou GS; Luo W; Li DH; Chen Y; Pan MX; Li X
    Antioxid Redox Signal; 2016 May; 24(14):795-812. PubMed ID: 26728324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
    França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
    Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor YY1 accelerates hepatic fibrosis development by activating NLRP3 inflammasome-mediated pyroptosis.
    Fu X; Xiao P; Luo X; Guo N
    Histol Histopathol; 2024 Aug; 39(8):1079-1087. PubMed ID: 38264929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.
    Li JP; Gao Y; Chu SF; Zhang Z; Xia CY; Mou Z; Song XY; He WB; Guo XF; Chen NH
    Acta Pharmacol Sin; 2014 Aug; 35(8):1031-44. PubMed ID: 24976156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway.
    Ishida K; Kaji K; Sato S; Ogawa H; Takagi H; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Yoshiji H
    J Nutr Biochem; 2021 Mar; 89():108573. PubMed ID: 33388347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lonicera japonica Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice: Molecular Mechanisms of Action.
    Miao H; Zhang Y; Huang Z; Lu B; Ji L
    Am J Chin Med; 2019; 47(2):351-367. PubMed ID: 30871359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oridonin ameliorates carbon tetrachloride-induced liver fibrosis in mice through inhibition of the NLRP3 inflammasome.
    Liu D; Qin H; Yang B; Du B; Yun X
    Drug Dev Res; 2020 Jun; 81(4):526-533. PubMed ID: 32219880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
    Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
    Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl
    Liu QQ; Chen J; Ma T; Huang W; Lu CH
    Sci Rep; 2024 Apr; 14(1):9425. PubMed ID: 38658618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xiaochaihutang attenuates liver fibrosis by activation of Nrf2 pathway in rats.
    Li J; Hu R; Xu S; Li Y; Qin Y; Wu Q; Xiao Z
    Biomed Pharmacother; 2017 Dec; 96():847-853. PubMed ID: 29078262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.